|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 35.20 USD | -1.10% |
|
-2.44% | -23.97% |
| 07-20 | Collegium Pharmaceutical to Relocate HQ to One Lincoln in Boston | MT |
| 05-16 | Collegium Pharmaceutical, Inc. Announces Appointment of Michael Donovan as Director | CI |
| Market Cap | 1.14B 1B 933M 856M 1.61B 110B 1.63B 11.07B 4.33B 54.05B 4.29B 4.19B 187B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 1.14B 1B 933M 856M 1.61B 110B 1.63B 11.07B 4.33B 54.05B 4.29B 4.19B 187B | EV / Sales 2026 * |
1.31x | EV / Sales 2027 * | 1.33x |
| Free-Float |
77.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Collegium Pharmaceutical, Inc.
| 1 day | -1.10% | ||
| 1 week | -2.44% | ||
| Current month | -2.76% | ||
| 1 month | +1.03% | ||
| 3 months | +8.31% | ||
| 6 months | -22.64% | ||
| Current year | -23.97% |
| 1 week | 34 |  | 36.92 |
| 1 month | 34 | | 38.5 |
| Current year | 30.13 | | 49.31 |
| 1 year | 29.19 | | 50.79 |
| 3 years | 20.95 | | 50.79 |
| 5 years | 14.04 | | 50.79 |
| 10 years | 7.37 | | 50.79 |
| Manager | Title | Age | Since |
|---|---|---|---|
Vikram Karnani
CEO | Chief Executive Officer | 51 | 12/11/2024 |
Colleen Tupper
DFI | Director of Finance/CFO | 50 | 24/05/2021 |
Scott Sudduth
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Garen Bohlin
BRD | Director/Board Member | 78 | 01/01/2015 |
Gino Santini
CHM | Chairman | 69 | 15/05/2025 |
John Freund
BRD | Director/Board Member | 72 | 01/02/2014 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/6/26 | Fiscal year | Chairman | 17,400 | 0.0536% | ||
| 18/5/26 | Sell | Director | -20 | 0.0001% | ||
| 15/5/26 | Fiscal year | Director | 21,527 | 0.0664% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.10% | -2.44% | +10.76% | +60.36% | 1.14B | |
| +0.86% | +1.43% | +47.17% | +161.40% | 1,067B | |
| +1.59% | +4.09% | +56.51% | +52.79% | 635B | |
| +0.95% | +1.91% | +36.30% | +83.13% | 458B | |
| +1.60% | +6.25% | +37.00% | +30.00% | 347B | |
| -0.60% | +1.52% | +36.67% | +39.80% | 295B | |
| -0.14% | +0.60% | +17.29% | +18.19% | 262B | |
| +0.09% | -2.82% | -29.09% | -41.29% | 216B | |
| +1.22% | +2.66% | +22.66% | +59.81% | 203B | |
| -1.18% | -3.70% | +11.28% | +67.43% | 161B | |
| Average | +0.33% | +0.95% | +24.66% | +53.16% | 364.41B | |
| Weighted average by Cap. | +0.76% | +1.95% | +35.99% | +78.15% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 870M 764M 710M 652M 1.23B 83.77B 1.24B 8.44B 3.3B 41.18B 3.27B 3.2B 142B | 860M 755M 703M 645M 1.21B 82.83B 1.23B 8.34B 3.26B 40.72B 3.23B 3.16B 141B |
| Net income | - | - |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/07/26 | US$35.20 | -1.10% | 254,181 |
| 23/07/26 | US$35.59 | +2.51% | 253,217 |
| 22/07/26 | US$34.72 | -3.15% | 231,337 |
| 21/07/26 | US$35.85 | +0.87% | 301,579 |
| 20/07/26 | US$35.54 | -1.50% | 383,546 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COLL Stock
Select your edition
All financial news and data tailored to specific country editions
